| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
145,055 |
142,100 |
$7.34M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89,941 |
87,861 |
$4.56M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
38,252 |
37,552 |
$3.07M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,880 |
36,286 |
$2.75M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
59,875 |
58,421 |
$1.76M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14,202 |
13,934 |
$1.11M |
| 87634 |
|
3,707 |
3,543 |
$194K |
| 71046 |
Radiologic examination, chest; 2 views |
9,215 |
9,035 |
$165K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,102 |
1,078 |
$134K |
| 74018 |
|
4,762 |
4,685 |
$82K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,735 |
2,407 |
$38K |
| 81003 |
|
10,685 |
10,428 |
$20K |
| 51701 |
|
286 |
275 |
$10K |
| 73610 |
|
362 |
355 |
$8K |
| 69210 |
|
129 |
125 |
$5K |
| 73630 |
|
210 |
204 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,684 |
6,557 |
$4K |
| 84703 |
|
630 |
604 |
$4K |
| 82947 |
|
1,004 |
946 |
$3K |
| 73140 |
|
136 |
134 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
191 |
186 |
$3K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
6,512 |
4,263 |
$2K |
| 94761 |
|
2,536 |
2,287 |
$2K |
| 29105 |
|
26 |
26 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
130 |
65 |
$2K |
| A4353 |
Intermittent urinary catheter, with insertion supplies |
304 |
290 |
$2K |
| 69209 |
|
109 |
106 |
$1K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
6,572 |
4,142 |
$1K |
| 73562 |
|
26 |
25 |
$648.80 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$528.66 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$417.09 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,535 |
1,046 |
$224.58 |
| 73090 |
|
13 |
13 |
$200.10 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
455 |
444 |
$30.23 |
| 99000 |
|
35 |
32 |
$22.36 |
| J3535 |
Drug administered through a metered dose inhaler |
12 |
12 |
$0.00 |
| Q0181 |
Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
28 |
28 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$0.00 |